Airway MedixWAR:AWM +0.93%17 EBITDA Margin % is -1,037.65% as of Mar. 2026. GuruFocus rates WAR:AWM with a GF Score™ of 17/100. The stock has 9 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Airway Medix ranks better than 99.88% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Airway Medix's EBITDA for the
three
months ended in Mar. 2026 was zł-0.88 Mil. Airway Medix's Revenue for the
three
months ended in Mar. 2026 was zł0.09 Mil. Therefore, Airway Medix's EBITDA margin for the quarter that ended in Mar. 2026 was -1,037.65%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Airway Medix EBITDA Margin % Related Terms
Airway Medix EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Airway Medix's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:AWM vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Airway Medix's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Airway Medix EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Airway Medix's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Airway Medix's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Airway Medix (WAR:AWM) has a EBITDA Margin % of -1,037.65% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Airway Medix and its competitors. According to the industry distribution chart, Airway Medix ranks #1 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 0.099999999999994%.
Is Airway Medix's EBITDA Margin % too high?
Airway Medix's current EBITDA Margin % is -1,037.65%. Based on the distribution chart, Airway Medix ranks #1 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Airway Medix has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Airway Medix's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Airway Medix ranks #1 out of 815 companies for EBITDA Margin %. This places Airway Medix in the top 0% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.47, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Airway Medix and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Airway Medix's current EBITDA Margin % is -1,037.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Airway Medix stock overvalued right now?
Airway Medix (WAR:AWM) has a current EBITDA Margin % of -1,037.65%. The current EBITDA Margin % is -1,037.65%. Airway Medix's overall GF Score™ is 17/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Airway Medix (WAR:AWM), the current EBITDA Margin % is -1,037.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Airway Medix SA focuses on research, development, and commercialization of devices for single use in mechanically ventilated patients at Intensive Care Units as well as in patients with life-threatening and anaesthesiologic wards. The company's products include the Closed Suction System, the Oral Care System, and the Cuff Pressure Regulator.
17GF Score
Get the complete analysis for WAR:AWM
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:AWM has been successfully added to your 
